These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7211092)

  • 1. Interstitial pituitary irradiation with 90Y for the treatment of acromegaly. A reappraisal.
    Cassar J; Doyle FH; Banks LM; Jadresic A; Mashiter K; Joplin GF
    Acta Endocrinol (Copenh); 1981 Mar; 96(3):295-300. PubMed ID: 7211092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of 90Y pituitary implantation in acromegaly.
    Jadresic A; Jimenez LE; Joplin GF
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):301-6. PubMed ID: 3618081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of rise in serum prolactin following yttrium-90 interstitial irradiation for acromegaly.
    Clark AJ; Chahal P; Mashiter K; Joplin GF
    Clin Endocrinol (Oxf); 1983 Nov; 19(5):557-63. PubMed ID: 6416717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients.
    Quabbe HJ
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):107-19. PubMed ID: 7067156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heel pad thickness is an insensitive index of biochemical remission in acromegaly.
    MacSweeney JE; Baxter MA; Joplin GF
    Clin Radiol; 1990 Nov; 42(5):348-50. PubMed ID: 2245573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial pituitary ablation with implants of gold-198 and yttrium-90 for acromegaly.
    HARTOG M; DOYLE F; FRASER R; JOPLIN GF
    Br Med J; 1965 Aug; 2(5458):396-8. PubMed ID: 20722184
    [No Abstract]   [Full Text] [Related]  

  • 7. Size and erosive features of the sella turcica in acromegaly as predictors of therapeutic response to supervoltage irradiation.
    Dons RF; Rieth KG; Gorden P; Roth J
    Am J Med; 1983 Jan; 74(1):69-72. PubMed ID: 6849329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of Cushing's disease using yttrium-90 rods.
    White MC; Doyle FH; Mashiter K; Joplin GF
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):280-2. PubMed ID: 6807451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of external beam radiotherapy for acromegaly is not affected by previous pituitary ablative treatments.
    Speirs CJ; Reed PI; Morrison R; Aber V; Joplin GF
    Acta Endocrinol (Copenh); 1990 May; 122(5):559-65. PubMed ID: 2353553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the visual field induced by intrasellar implantation of 90Y in 104 acromegalic patients and their subsequent course].
    Liuzzi L; Dossi F
    Arch Sci Med (Torino); 1972; 129(4):252-72. PubMed ID: 17340698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the metabolism of calcium and phosphorus in the various phases of acromegaly and following the implantation of the pituitary gland with 90Y.
    MOLINATTI GM; CAMANNI F; LOSANA O; OLIVETTI M
    Acta Endocrinol (Copenh); 1961 Feb; 36():161-79. PubMed ID: 13771825
    [No Abstract]   [Full Text] [Related]  

  • 12. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.
    Jenkins PJ; Bates P; Carson MN; Stewart PM; Wass JA
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1239-45. PubMed ID: 16403824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours.
    Jadresic A; Banks LM; Child DF; Diamant L; Doyle FH; Fraser TR; Joplin GF
    Q J Med; 1982; 51(202):189-204. PubMed ID: 7111679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sellar reconstitution and serum levels of growth hormone in acromegaly before and after pituitary implant.
    McLachlan MS; Wright AD; Doyle FH; Fraser TR
    Clin Radiol; 1971 Oct; 22(4):502-6. PubMed ID: 5135820
    [No Abstract]   [Full Text] [Related]  

  • 15. Acromegaly with sleep disturbances relieved by yttrium-90 pituitary implantation.
    Rosenstock J; Jung RT; Doyle FH; Mashiter K; Joplin GF
    J R Soc Med; 1982 Mar; 75(3):209-10. PubMed ID: 7069686
    [No Abstract]   [Full Text] [Related]  

  • 16. The spontaneous course of pituitary adenomas and occurrence of an empty sella in untreated acromegaly.
    Bjerre P; Lindholm J; Videbaek H
    J Clin Endocrinol Metab; 1986 Aug; 63(2):287-91. PubMed ID: 3722323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current indications of stereotaxic interstitial irradiation in acromegaly. Ophthalmologic and neuroendocrinologic correlations in relation to prolonged time].
    Talairach J; Schaub C; Szikla G; Recoules D; Boujard O; Bleut-Pajot MT; Nassiet J; Lornet C
    Neurochirurgie; 1974; 20(4):369-90. PubMed ID: 4377577
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.
    Barkan AL; Halasz I; Dornfeld KJ; Jaffe CA; Friberg RD; Chandler WF; Sandler HM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3187-91. PubMed ID: 9329336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of conventional pituitary irradiation in acromegaly.
    Roth J; Gorden P; Brace K
    N Engl J Med; 1970 Jun; 282(25):1385-91. PubMed ID: 5445526
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors determining the long-term outcome of surgery for acromegaly.
    Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
    QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.